| Ytd | 53.58% | |
| 1y | 117.61% |
| Open | 38.84 | Prev Close | 39.53 | Low | 38.77 | High | 39.43 | Mkt Cap | 8.27B |
| Vol | 579.49K | Avg Vol | 1.82M | EPS | -2.77 | P/E | -14.62 | Forward P/E | -16.30 |
| Beta | 0.77 | Short Ratio | 10.32 | Inst. Own | 54.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 34.32 | 200-d Avg | 26.92 | 1yr Est | 47.19 |
IMVT News
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
Citigroup analyst Samantha Semenkow maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock?
IMVT shares climb as IMVT-1402 posts encouraging data, advances across autoimmune diseases and benef
Wall Street analysts changed outlook on top names. Guggenheim raised price target for IMVT, Piper Sa
Immunovant's underlying bull case has now moved away from batoclimab and toward IMVT-1402. This newe
Roivant (ROIV) remains a Buy as its unique 'vant' structure rapidly advances and monetizes blockbust
Immunovant Inc (NASDAQ:IMVT) on Wednesday posted a wider fourth‑quarter loss than analysts expected.
Immunovant stock jumps 35% as strong early IMVT-1402 data in rheumatoid arthritis boosts confidence
Immunovant Inc (NASDAQ:IMVT) shares are trading higher on Wednesday even though the company posted a
US stocks rise with Dow gaining 1% on Wednesday. The Nasdaq and S&P 500 also saw gains. Lowe'
Roivant executives used the company's fourth-quarter and fiscal-year earnings call to highlight new
TAT Technologies Ltd (TATT) reported better-than-expected Q1 results, sending shares up 11.7%. Other
DURHAM, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage imm
DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it wil
Immunovant, Inc. (NASDAQ: IMVT - Get Free Report) CTO Jay Stout sold 2,754 shares of Immunovant stoc
Arcus Biosciences (NYSE: RCUS - Get Free Report) and Immunovant (NASDAQ: IMVT - Get Free Report) are
Immunovant slips 2.4% after batoclimab misses key phase III endpoints in thyroid eye disease trials,
Roivant Sciences and Priovant Therapeutics executives outlined an expansion of the brepocitinib deve
Immunovant, Inc. (IMVT) Discusses Brepocitinib Program Expansion and Batoclimab Phase III Data Updat
Dow futures down 400 points, Alto Neuroscience shares dip 13.6% after Phase 2 trial results, other s
GSAT: 24% | Globalstar shares are trading higher following reports suggesting that Amazon is in disc
Amazon may acquire Globalstar Inc., shares soared in pre-market trading. Other gainers include Turbo
Immunovant said on Thursday that its therapy to treat a type of eye disease failed to meet
Lichen planopilaris (LPP) is a highly morbid inflammatory scalp disorder that causes generally irrev
Logos added 1.1 million shares of Immunovant last quarter, a purchase estimated at about $24.5 milli
Alpine Global Management sold 128,039 shares of Immunovant in the fourth quarter; the estimated tran
During Monday's trading, 1214 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
On Friday, 209 companies set new 52-week lows.
This morning 239 companies reached new 52-week highs.
This morning 221 companies reached new 52-week highs.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Highs On Thursday